| Discovery | Candidate | Preclinical | Clinical | Partner | |
|---|---|---|---|---|---|
| A2aR/A2bR antagonist + |
Preclinical
|
||||
| EP4R antagonist (DT-9081) + | Preclinical | ||||
| Anti-CCR8 antibody + | Discovery | ||||
| Undisclosed GPCR targets + | Discovery | ||||
| Multi-target collaboration for CNS + |
Discovery
|
||||
| mGluR4/7/8 PAM + | Candidate | ||||
| NPFFR antagonist + | Discovery | ||||
| MC4R pharmacochaperone + |
Discovery
|
||||
| PAR2 NAM + | Discovery | ||||
| Multi-target collaboration for rare diseases + |
Discovery
|
||||
| CXCR4 biased agonist + |
Discovery
|
||||
| SEMA3 + | Discovery | ||||
| Undisclosed targets + | Discovery | ||||
